Tnb Financial Holding in Cvs Health Corporation (CVS) Has Upped as Market Valuation Declined

March 14, 2018 - By Winifred Garcia

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It dropped, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Westchester Cap Incorporated owns 104,375 shares or 3.64% of their US portfolio. Villere St Denis J And Communication Ltd Liability Co accumulated 0.01% or 2,500 shares. The Oregon-based Pioneer Tru Commercial Bank N A Or has invested 0.67% in CVS Health Corporation (NYSE:CVS). St Germain D J holds 2.19% in CVS Health Corporation (NYSE:CVS) or 214,835 shares. Moreover, Charter Trust has 0.21% invested in CVS Health Corporation (NYSE:CVS). Bartlett & Co Ltd Liability Corporation has invested 1.62% in CVS Health Corporation (NYSE:CVS). Moreover, Genesee Valley has 0.4% invested in CVS Health Corporation (NYSE:CVS). Renaissance Gp Ltd Llc has 401,475 shares for 1.12% of their portfolio. Markston Intll Limited Liability reported 229,223 shares. 29,596 are owned by Compton Capital Mngmt Ri. 2,650 are owned by Hite Hedge Asset Mgmt Lc. Burke Herbert Bank Com invested 0.54% of its portfolio in CVS Health Corporation (NYSE:CVS). The Massachusetts-based Northeast Invest Mngmt has invested 2.11% in CVS Health Corporation (NYSE:CVS). California Pub Employees Retirement System stated it has 0.3% in CVS Health Corporation (NYSE:CVS). Rhumbline Advisers invested in 1.88M shares or 0.33% of the stock.

Since September 15, 2017, it had 0 insider purchases, and 3 sales for $10.21 million activity. Roberts Jonathan C also sold $7.13 million worth of CVS Health Corporation (NYSE:CVS) on Monday, September 18. Moriarty Thomas M sold $1.67 million worth of stock or 20,547 shares.

Tnb Financial increased its stake in Cvs Health Corporation (CVS) by 1091.19% based on its latest 2017Q3 regulatory filing with the SEC. Tnb Financial bought 127,178 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 138,833 shares of the medical and nursing services company at the end of 2017Q3, valued at $11.29M, up from 11,655 at the end of the previous reported quarter. Tnb Financial who had been investing in Cvs Health Corporation for a number of months, seems to be bullish on the $67.87B market cap company. The stock decreased 1.97% or $1.345 during the last trading session, reaching $66.905. About 5.10 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since March 14, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Tnb Financial, which manages about $602.89M US Long portfolio, decreased its stake in Express Scripts Hldg Co Com (NASDAQ:ESRX) by 152,337 shares to 7,363 shares, valued at $466,000 in 2017Q3, according to the filing.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: “Hyman Charles D Buys MetLife Inc, Goldman Sachs Group Inc, Morgan Stanley …” on March 13, 2018, also with their article: “Why CVS Health Corporation Sank 14% in February” published on March 06, 2018, published: “Bears Still Have Their Claws Into CVS Health” on March 07, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: “CVS’s $40 billion debt deal to fund Aetna takeover puts credit rating in peril” published on March 06, 2018 as well as‘s news article titled: “AMA Stops Short Of Asking Regulators To Block CVS-Aetna Deal” with publication date: February 27, 2018.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 73 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Hold” rating by Loop Capital on Tuesday, November 7. The rating was maintained by Cowen & Co with “Buy” on Tuesday, June 13. The firm has “Buy” rating by Tigress Financial given on Tuesday, December 26. SunTrust maintained CVS Health Corporation (NYSE:CVS) rating on Thursday, January 4. SunTrust has “Buy” rating and $90.0 target. The rating was maintained by Citigroup on Friday, November 3 with “Neutral”. Argus Research maintained CVS Health Corporation (NYSE:CVS) on Monday, August 10 with “Buy” rating. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) on Tuesday, August 8 with “Buy” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Neutral” rating by Citigroup on Monday, May 9. On Tuesday, January 2 the stock rating was maintained by Needham with “Buy”. Robert W. Baird downgraded CVS Health Corporation (NYSE:CVS) on Thursday, February 2 to “Neutral” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: